Literature DB >> 23374215

Sensitive detection of human breast cancer cells based on aptamer-cell-aptamer sandwich architecture.

Xiaoli Zhu1, Jinghua Yang, Min Liu, Yao Wu, Zhongming Shen, Genxi Li.   

Abstract

Breast cancer is one of the most critical threats to the health of women, and the development of new methods for early diagnosis is urgently required, so this paper reports a method to detect Michigan cancer foundation-7 (MCF-7) human breast cancer cells with considerable sensitivity and selectivity by using electrochemical technique. In this method, a mucin 1 (MUC1)-binding aptamer is adopted to recognize MCF-7 human breast cancer cells, while enzyme labeling is employed to produce amplified catalytic signals. The molecular recognition and the signal amplification are elaborately integrated by fabricating an aptamer-cell-aptamer sandwich architecture on an electrode surface, thus a biosensor for the detection of MCF-7 is fabricated based on the architecture. The detection range can be from 100 to 1×10(7) cells, and the detection limit can be as low as 100 cells. The method is also cost-effective and conveniently operated, implying potential help for the development of early diagnosis of breast cancer.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23374215     DOI: 10.1016/j.aca.2012.12.024

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  9 in total

1.  Dual-aptamer based electrochemical sandwich biosensor for MCF-7 human breast cancer cells using silver nanoparticle labels and a poly(glutamic acid)/MWNT nanocomposite.

Authors:  Samira Yazdanparast; Ali Benvidi; Maryam Banaei; Habib Nikukar; Marzieh Dehghan Tezerjani; Mostafa Azimzadeh
Journal:  Mikrochim Acta       Date:  2018-08-09       Impact factor: 5.833

2.  Cancer biomarker profiling using nanozyme containing iron oxide loaded with gold particles.

Authors:  Victor Akpe; Muhammad J A Shiddiky; Tak H Kim; Christopher L Brown; Yusuke Yamauchi; Ian E Cock
Journal:  J R Soc Interface       Date:  2020-06-24       Impact factor: 4.118

3.  Application of aptamers in diagnostics, drug-delivery and imaging.

Authors:  Chetan Chandola; Sheetal Kalme; Marco G Casteleijn; Arto Urtti; Muniasamy Neerathilingam
Journal:  J Biosci       Date:  2016-09       Impact factor: 2.795

4.  Aptamer-conjugated Magnetic Nanoparticles as Targeted Magnetic Resonance Imaging Contrast Agent for Breast Cancer.

Authors:  Mohammad Keshtkar; Daryoush Shahbazi-Gahrouei; Seyyed Mehdi Khoshfetrat; Masoud A Mehrgardi; Mahmoud Aghaei
Journal:  J Med Signals Sens       Date:  2016 Oct-Dec

Review 5.  Current Advances in Aptamers for Cancer Diagnosis and Therapy.

Authors:  Shin-Ichiro Hori; Alberto Herrera; John J Rossi; Jiehua Zhou
Journal:  Cancers (Basel)       Date:  2018-01-03       Impact factor: 6.639

Review 6.  Aptamer-based sandwich-type biosensors.

Authors:  Ho Bin Seo; Man Bock Gu
Journal:  J Biol Eng       Date:  2017-03-13       Impact factor: 4.355

7.  Surface-Enhanced Carboxyphenyl Diazonium Functionalized Screen-Printed Carbon Electrode for the Screening of Tuberculosis in Sputum Samples.

Authors:  Muhammad Hafiznur Yunus; Nor Azah Yusof; Suhainie Ismail; Siti Suraiya Md Noor; Faruq Mohammad; Yusran Sulaiman; Nurul Hanun Ahmad Raston; Jaafar Abdullah; Ahmed A Soleiman
Journal:  Nanomaterials (Basel)       Date:  2022-07-25       Impact factor: 5.719

8.  Exploring the Utility of ssDNA Aptamers Directed against Snake Venom Toxins as New Therapeutics for Snakebite Envenoming.

Authors:  Nessrin Alomran; Raja Chinnappan; Jaffer Alsolaiss; Nicholas R Casewell; Mohammed Zourob
Journal:  Toxins (Basel)       Date:  2022-07-08       Impact factor: 5.075

9.  Detection and Identification of Hematologic Malignancies and Solid Tumors by an Electrochemical Technique.

Authors:  Yujie Wang; Bowen Zhang; Xiaoping Zhang; Xuemei Wang; Jian Cheng; Baoan Chen
Journal:  PLoS One       Date:  2016-04-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.